YOQNEAM, Israel,
Nov. 12, 2019 /PRNewswire/
-- InMode Ltd. (Nasdaq: INMD) ("InMode"), a
leading global provider of innovative medical technologies,
announced today that Moshe Mizrahy,
Chairman and Chief Executive Officer, will present at the Canaccord
Genuity MedTech & Diagnostics Forum at the Westin Grand
Central, New York City on
November 21st at
11:30 am EST.
Mr. Mizrahy will be available for one-on-one meetings
during the conference. To schedule a meeting please contact your
Canaccord salesperson or Miri Segal
at msegal@ms-ir.com.
A live webcast of the presentation will be available to
the public
at: http://wsw.com/webcast/canaccord37/inmd/.
The webcast will be archived for 90 days following the live
presentation.
About Canaccord Genuity MedTech & Diagnostics
Forum
Canaccord's MedTech Conference will profile public and
private Med-Tech and Diagnostic companies in Cardiovascular,
Diabetes, ENT, Respiratory, Wound Care, Women's Healthcare,
Ophthalmology, Aesthetics, Obesity, Robotics & Imaging,
Diagnostics, Liquid Biopsies, Precision Medicine and Next
Generation Sequencing.
About InMode
InMode is a leading global provider of innovative medical
technologies. InMode develops, manufactures, and markets
devices harnessing novel radio-frequency ("RF") technology.
InMode strives to enable new emerging surgical procedures as well
as improve existing treatments. InMode has leveraged its
medically-accepted minimally-invasive RF technologies to offer a
comprehensive line of products across several categories for
plastic surgery, gynecology, dermatology, otolaryngology, and
ophthalmology. For more information about InMode, please
visit www.inmodemd.com.
Investor Relations Contact:
Miri
Segal
MS-IR LLC
Phone: (917)
607-8654
Email: ir@inmodemd.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/inmode-to-present-at-canaccord-genuity-medtech--diagnostics-forum-300955739.html
SOURCE InMode